本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CALCIMEDICA

0.6551
-0.0449-6.41%
盤後0.66860.0135+2.06%19:17 EST
成交量:36.43萬
成交額:24.42萬
市值:943.96萬
市盈率:-0.41
高:0.7110
開:0.7110
低:0.6500
收:0.7000
52周最高:7.20
52周最低:0.5201
股本:1,440.94萬
流通股本:669.63萬
量比:0.77
換手率:5.44%
股息:- -
股息率:- -
每股收益(TTM):-1.6136
每股收益(LYR):-1.2182
淨資產收益率:-526.36%
總資產收益率:-100.03%
市淨率:-35.22
市盈率(LYR):-0.54

資料載入中...

公司資料

公司名字:
CALCIMEDICA
交易所:
NASDAQ
成立時間:
- -
員工人數:
15
公司地址:
505 Coast Boulevard South,Suite 307,La Jolla,California,United States
郵編:
92037
電話:
傳真:
- -
簡介:
CalciMedica, Inc.於2015年2月根據特拉華州法律成立。該公司是一家臨床階段的生物製藥公司,專註於開發治療由炎症和免疫過程以及直接細胞損傷驅動的嚴重疾病的療法。公司候選產品作用於鈣釋放活化鈣(“CRAC”)通道,將構成一類新藥。

董事

名稱
職位
A. Rachel Leheny
Chief Executive Officer and Director
Eric W. Roberts
Chief Business Officer and Director,vice chairman
Robert N. Wilson
Director,Chair
Allan Shaw
Director
Eric Bjerkholt
Director
Fred Middleton
Director
Frederic Guerard
Director

股東

名稱
職位
A. Rachel Leheny
Chief Executive Officer and Director
Michael J. Dunn
President and Chief Operating Officer
Daniel Geffken
Interim Chief Financial Officer
Eric W. Roberts
Chief Business Officer and Director,vice chairman
Kenneth A. Stauderman
Chief Scientific Officer
Sudarshan Hebbar
Chief Medical Officer